Treatment rankings
| Treatment | |||
|---|---|---|---|
| Rank* | Placebo | DPP-4 | NPH |
| 1 | 0.00 (0.00) | 0.50 (0.50) | 0.50 (0.50) |
| 2 | 0.08 (0.08) | 0.50 (1.00) | 0.42(0.92) |
| 3 | 0.92 (1.00) | 0.00 (1.00) | 0.08 (1.00) |
| SUCRA | 4.22% | 74.89% | 70.89% |
*Reported as the probability to achieve each of the three ranks and cumulative rank probabilities (in parenthesis).
DPP-4, dipeptidyl peptidase-4 inhibitors; NPH, neutral protamine Hagedorn; SUCRA, surface under cumulative ranking curve.